{"id":"W4400094794","doi":"10.1016/j.jtct.2024.06.021","title":"Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Seagen; Swedish Orphan Biovitrum; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Data collection; Family medicine; Statistics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001662284,0.0001484494,0.0001968711,0.000501974,0.0001212657,0.00009593627,0.0001155424,0.0001167029,0.000006962171],"category_scores_gemma":[0.00001705923,0.00008257465,0.00003283157,0.0005700876,0.0002149666,0.000127826,0.000009619276,0.0005171712,7.78385e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003211558,"about_ca_system_score_gemma":0.00004576335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004267639,"about_ca_topic_score_gemma":0.0004362376,"domain_scores_codex":[0.998381,0.0003184103,0.0003121617,0.000366277,0.0004393926,0.000182793],"domain_scores_gemma":[0.9992437,0.0004191441,0.00005012699,0.0001808346,0.00006834957,0.00003778071],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00464616,0.002173079,0.6927004,0.0007125183,0.0004393911,0.0003271529,0.1070682,0.000008409957,0.02067056,0.001471504,0.00009811315,0.1696846],"study_design_scores_gemma":[0.01674289,0.0007138337,0.9468377,0.0006424324,0.0001009001,0.00009056984,0.002570158,0.01856344,0.004246286,0.002149177,0.007051405,0.0002911511],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853495,0.00210306,0.0006002804,0.01069045,0.0001764893,0.0009165935,0.0001167047,0.00001456873,0.00003234793],"genre_scores_gemma":[0.976904,0.02116903,0.0000324349,0.000178262,0.00003321263,0.00009595111,0.001546696,0.00001267595,0.00002774699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2541374,"threshold_uncertainty_score":0.3367296,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1070718053539612,"score_gpt":0.3926015508572358,"score_spread":0.2855297455032746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}